We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.

Delisted

CEMI was delisted on the 27th of April, 2023.

17 hedge funds and large institutions have $4.76M invested in Chembio diagnostics, Inc. in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

4.74% less ownership

Funds ownership: 18.36%13.63% (-4.7%)

6% less funds holding

Funds holding: 1817 (-1)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

46% less capital invested

Capital invested by funds: $8.82M → $4.76M (-$4.06M)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

CEMI Hedge Fund Activity: Q3 2013 in Review

17 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2013, worth a combined $4.76M — down 46% from $8.82M a quarter earlier.

Fund positioning in CEMI was balanced in Q3 2013: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $482K. The largest seller was Northpointe Capital, exiting entirely with an estimated $1.62M sold.

  • 17 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2013, down from 18 in Q2 2013.
  • Funds reported $4.76M of Chembio diagnostics, Inc. stock for Q3 2013, down 46% quarter-over-quarter.
  • 4 funds opened new Chembio diagnostics, Inc. positions in Q3 2013 and 4 closed out, a net change of 0 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q3 2013 was Vanguard Group, an estimated $482K added.
  • The largest Chembio diagnostics, Inc. seller in Q3 2013 was Northpointe Capital, an estimated $1.62M sold.

Based on aggregated 13F filings for Q3 2013.